Global Feed Post Login
Replying to Avatar ish4k

"Lenacapavir, sold as Sunlenca by US pharmaceutical giant Gilead, currently costs $42,250 for the first year. The company is being urged to make it available at a thousand times less than that price worldwide."

https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

Avatar
pseudo~u *likes nostr already* 1y ago

Do the side effects of this one include aids too?

Reply to this note

Please Login to reply.

Discussion

No replies yet.